Tolerance of volunteers to cyclosporine A-dilauroylphosphatidylcholine liposome aerosol

American Journal of Respiratory and Critical Care Medicine

Volumn 156, Issue 6, 1997, Pages 1789-1793

  Gilbert, Brian E ^a   Knight, Caroline ^a   Alvarez, Francisco G ^a   Waldrep, J Clifford ^a   Rodarte, Joseph R ^a   Knight, Vernon ^a   Eschenbacher, William L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DILAUROYLPHOSPHATIDYLCHOLINE;

ADULT; AEROSOL; ARTICLE; ASTHMA; CLINICAL TRIAL; DRUG MECHANISM; DRUG TOLERANCE; FACE MASK; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INHALATIONAL DRUG ADMINISTRATION; MALE; NORMAL HUMAN; PARTICLE SIZE; PRIORITY JOURNAL; SPIROMETRY;

EID: 0031467944     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.156.6.9702101     Document Type: Article

References (17)

1. Nizankowska, E., R. Dworski, and A. Szczeklik. 1991. Cyclosporin for severe case of aspirin-induced asthma. Eur. Respir. J. 4:380.
2. Szczeklik, A., E. Nizankowska, and R. Dworski. 1991. Cyclosporin for steroid-dependent asthma. Allergy 46:312-315.
3. Nizankowska, E., J. Soja, G. Pinis, G. Bochenek, K. Sladek, B. Domagala, A. Pajak, and A. Szczeklik. 1995. Treatment of steroid-dependent bronchial asthma with Cyclosporin. Eur. Respir. J. 8:1091-1099.
4. Klein, R. M., M. Leschke, and B. E. Stauer. 1995. Cyclosporin in chronic severe corticosteroid-dependent bronchial asthma. Dtsch. Med. Wochenschr. 120:1349-1355.
5. Alexander, A. G., N. C. Barnes, and A. B. Kay. 1992. Trial of cyclosporin in corticosteroid-dependent chronic severe asthma. Lancet 339:324-328.
6. Lock, S. H., A. B. Kay, and N. C. Barnes. 1996. Double-blind, placebo controlled study of Cyclosporin A as a corticosteroid-sparing agent in corticosteroid-dependent asthma. Am. J. Respir. Crit. Care Med. 153:509-514.
7. Martinet, Y., P. Pinkston, C. Saltini, J. Spurzem, J. Muller-Quernheim, and R. G. Crystal. 1988. Evaluation of the in vitro and in vivo effects of cyclosporine on the lung T-lymphocyte alveolitis of active pulmonary sarcoidosis. Am. Rev. Respir. Dis. 138:1242-1248.
8. Waldrep, J. C., P. W. Scherer, K. Keyhani, and V. Knight. 1993. Cyclosporin-A liposome aerosol - particle size and calculated respiratory deposition. Int. J. Pharm. 97:205-212.
9. Gilbert, B. E., S. Z. Wilson, N. M. Garcon, P. R. Wyde, and V. Knight. 1993. Characterization and administration of cyclosporine liposomes as a small-particle aerosol. Transplantation 56:974-977.
10. Gilbert, B. E., M. B. Black, J. C. Waldrep, J. Bennick, C. Montgomery, and V. Knight. 1997. Cyclosporin A liposome aerosol: lack of acute toxicity in rats with a high incidence of underlying pneumonitis. Inhal. Toxicol. 9:717-730.
11. American Thoracic Society. 1987. Standardization of spirometry - 1987 update. Am. Rev. Respir. Dis. 136:1285-1298.
12. Crapo, R. O., A. H. Morris, and R. M. Gardner. 1981. Reference spirometric values using techniques and equipment that meet ATS recommendations. Am. Rev. Respir. Dis. 123:659-664.
13. Knight, V., B. E. Gilbert, and S. Z. Wilson. 1986. Ribavirin small particle aerosol treatment of influenza and respiratory syncytial virus infections. In T. Stapleton, editor. Studies with a Broad Spectrum Antiviral Agent. Royal Society of Medicine Series, New York. 37.
14. Waldrep, J. C., P. W. Scherer, G. D. Hess, M. Black, and V. Knight. 1994. Nebulized glucocorticoids in liposomes: aerosol characteristics and human dose estimates. J. Aerosol. Med. 7:135-145.
15. Phalen, R. F. 1984. Inhalation Studies: Foundations and Techniques. CRC Press, Boca Raton, FL.
16. Persons, D. D., G. D. Hess, W. J. Muller, and P. W. Scherer. 1987. Airway deposition of hygroscopic heterodispersed aerosols: results of a computer calculation. J. Appl. Physiol. 63:1195-1204.
17. 99mTc-labeled beclomethasone liposomes in mild and severe asthmatics (abstract). American Lung Association/American Thoracic Society International Conference 1997.